Already at best price
Nixha-M Tablet SR
Metformin (500mg) + Myo-Inositol (600mg)
Neocell Science Pharmaceuticals Pvt Ltd
Anti-Diabetic
₹212.00
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
₹212.00
Active composition
Metformin 500 mg
+1 more active ingredient
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medicine Strength
500 mg
All Active Ingredients
Metformin500 mg
Myo-Inositol600 mg
Uses & Benefits
Medical applications
Diabetes
Nixha-M Tablet SR is a prescription medication, a combination of Metformin (500mg) and Myo-Inositol (600mg). Indicated for the management of type 2 diabetes mellitus, it helps control high blood sugar levels by decreasing the amount of sugar produced by the liver and improving your body's response to insulin. The sustained-release formula provides a consistent release of the active ingredients, aiming to maintain stable blood sugar levels throughout the day. However, it's crucial to remember that Nixha-M Tablet SR is not a cure for diabetes and should be used in conjunction with a balanced diet and regular exercise. Consult your healthcare provider for appropriate dosage and monitoring of therapeutic effectiveness and potential side effects.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
✓Only 2.3% reported effects
Common Side Effects
Headache8%
Nausea5%
Higher
Lower
Safety Advice
Alcohol
Information regarding the use of Nixha-M Tablet SR during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Nixha-M Tablet SR during breastfeeding is not available. Please consult your doctor.
Medical Advice
Driving
Nixha-M Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Nixha-M Tablet SR may be needed. Please consult your doctor. Use of Nixha-M Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Breastfeeding
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Nixha-M Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Nixha-M Tablet SR may be needed. Please consult your doctor. Nixha-M Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Customer Reviews
0 reviews for Nixha-M Tablet SR
Nixha-M Tablet SR
1 / 3
Rx RequiredSchedule H
Nixha-M Tablet SR
Metformin (500mg) + Myo-Inositol (600mg)
₹212.00
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
Cheaper alternative availability
Not Foundfor this medicine
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Metformin 500 mg
+1 more active ingredient
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medicine Strength
500 mg
All Active Ingredients
Metformin500 mg
Myo-Inositol600 mg
Uses & Benefits
Medical applications
Diabetes
Nixha-M Tablet SR is a prescription medication, a combination of Metformin (500mg) and Myo-Inositol (600mg). Indicated for the management of type 2 diabetes mellitus, it helps control high blood sugar levels by decreasing the amount of sugar produced by the liver and improving your body's response to insulin. The sustained-release formula provides a consistent release of the active ingredients, aiming to maintain stable blood sugar levels throughout the day. However, it's crucial to remember that Nixha-M Tablet SR is not a cure for diabetes and should be used in conjunction with a balanced diet and regular exercise. Consult your healthcare provider for appropriate dosage and monitoring of therapeutic effectiveness and potential side effects.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
✓Only 2.3% reported effects
Common Side Effects
Headache8%
Nausea5%
Higher
Lower
Safety Advice
Alcohol
Information regarding the use of Nixha-M Tablet SR during pregnancy is not available. Please consult your doctor.
High Risk
Pregnancy
Information regarding the use of Nixha-M Tablet SR during breastfeeding is not available. Please consult your doctor.
Medical Advice
Driving
Nixha-M Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Nixha-M Tablet SR may be needed. Please consult your doctor. Use of Nixha-M Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Breastfeeding
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Nixha-M Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Nixha-M Tablet SR may be needed. Please consult your doctor. Nixha-M Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Customer Reviews
0 reviews for Nixha-M Tablet SR
%22%2F%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22158%22%20font-family%3D%22system-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%2Csans-serif%22%20font-size%3D%2244%22%20font-weight%3D%22800%22%20text-anchor%3D%22middle%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.45%22%20transform%3D%22rotate(-16%20150%20158)%22%3EDrugIndia%3C%2Ftext%3E%0A%3Cg%20fill%3D%22%23fb7185%22%20opacity%3D%220.5%22%3E%3Cpath%20d%3D%22M44%2048h6v6h6v6h-6v6h-6v-6h-6v-6h6z%22%2F%3E%3Cpath%20d%3D%22M250%20214h5v5h5v5h-5v5h-5v-5h-5v-5h5z%22%2F%3E%3C%2Fg%3E%0A%3Cellipse%20cx%3D%22150%22%20cy%3D%22120%22%20rx%3D%22118%22%20ry%3D%2286%22%20fill%3D%22url(%23glow)%22%2F%3E%0A%3Cg%20transform%3D%22rotate(-28%20150%20120)%22%20filter%3D%22url(%23soft)%22%20font-family%3D%22system-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%2Csans-serif%22%3E%0A%3Crect%20x%3D%2289%22%20y%3D%2297%22%20width%3D%22122%22%20height%3D%2246%22%20rx%3D%2223%22%20fill%3D%22url(%23cap)%22%2F%3E%0A%3Cpath%20d%3D%22M89%20120a23%2023%200%200%201%2023-23h38v46h-38a23%2023%200%200%201-23-23z%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.16%22%2F%3E%0A%3Cline%20x1%3D%22150%22%20y1%3D%2298%22%20x2%3D%22150%22%20y2%3D%22142%22%20stroke%3D%22%23ffffff%22%20stroke-width%3D%222%22%20opacity%3D%220.55%22%2F%3E%0A%3Cellipse%20cx%3D%22118%22%20cy%3D%22110%22%20rx%3D%2215%22%20ry%3D%225%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.4%22%2F%3E%0A%3C%2Fg%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22206%22%20font-size%3D%2222%22%20font-weight%3D%22700%22%20letter-spacing%3D%220.2%22%20text-anchor%3D%22middle%22%20fill%3D%22%237c2d12%22%3ESITARAY%20M%3C%2Ftext%3E%3Ctext%20x%3D%22150%22%20y%3D%22232%22%20font-size%3D%2222%22%20font-weight%3D%22700%22%20letter-spacing%3D%220.2%22%20text-anchor%3D%22middle%22%20fill%3D%22%237c2d12%22%3E50%2F500MG%20TAB%3C%2Ftext%3E%0A%3Cg%20font-family%3D%22system-ui%2C-apple-system%2CSegoe%20UI%2CRoboto%2Csans-serif%22%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22271%22%20font-size%3D%2215%22%20font-weight%3D%22800%22%20letter-spacing%3D%221.5%22%20text-anchor%3D%22middle%22%20fill%3D%22%23ffffff%22%20opacity%3D%220.85%22%3EDRUGINDIA%3C%2Ftext%3E%0A%3Ctext%20x%3D%22150%22%20y%3D%22270%22%20font-size%3D%2215%22%20font-weight%3D%22800%22%20letter-spacing%3D%221.5%22%20text-anchor%3D%22middle%22%20fill%3D%22%23c2410c%22%3EDRUGINDIA%3C%2Ftext%3E%0A%3C%2Fg%3E%0A%3C%2Fsvg%3E)